"BX04" . "Denosumab is a fully human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone. It was developed by the biotechnology company Amgen.In June 2010, denosumab was approved by the U.S."@en . "M05" . "615258-40-7" . "4EQZ6YO2HI" .